Continue
By using our website you accept our cookies policy.Find out more

KTN appoints new CEO

Posted on 01/03/2019

David Lawrence, Chairman KTN Ltd
The KTN Board is pleased to announce that Dr Alicia Greated has been appointed as the new CEO of Knowledge Transfer Network Ltd, from late 2019.

“We’re delighted that Alicia will be joining us as KTN Ltd CEO later this year. She is a proven leader, with the experience and drive to implement our ambition and strategy during this exciting period of growth for KTN.”

Dr Alicia Greated has been Director of Research and Enterprise at Heriot-Watt University since December 2015.  Prior to that, she led the Newton Fund (a £735 million research and innovation fund to enhance the UK’s engagement with global emerging economies) delivery team at the UK’s Department of Business, Energy & Industrial Strategy (BEIS).

In 2008, Alicia moved to Delhi, India where she was founder and Director of Research Council UK (RCUK) India at the British High Commission. After four years in India, she moved to Beijing to become Director RCUK China at the British Embassy in Beijing.

Alicia has also worked as acting Director of Research for the Arts and Humanities Research Council (AHRC), and spent five years at the Engineering and Physical Sciences Research Council (EPSRC) where she was Head of Engineering.

Alicia has a PhD in Molecular Genetics. She is a Fellow of the Institution of Engineering and Technology, a member of the Scottish Funding Councils Research and Knowledge Exchange Committee and a Governor on Heriot-Watt University’s Court.

“I am very excited and honoured to be joining the KTN team. I look forward to building on the important contributions the KTN has already made in stimulating innovation to strengthen the UK economy – ultimately enhancing the lives of those around us” – Dr Alicia Greated.

Alicia will be taking over in late 2019 from Chris Warkup, who has announced his retirement after leading the organisation since its formation in April 2014.

Chris Warkup will be retiring in April 2019, and Sue Dunkerton will take up the post of interim CEO from then until Dr Greated takes over the role.

Related Content